A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG)

被引：0
|
作者：
Lesser, G. J. [1 ]
Stieber, V. [1 ]
Case, D. [1 ]
Enevold, G. [1 ]
Rosdhal, R. [1 ]
Tatter, S. [1 ]
Ellis, T. [1 ]
McMullen, K. [1 ]
Shaw, E. [1 ]
机构：
[1] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG).
    Kaley, Thomas Joseph
    Pentsova, Elena
    Omuro, Antonio Marcilio Padula
    Mellinghoff, Ingo K.
    Nolan, Craig
    Gavrilovic, Igor T.
    DeAngelis, Lisa Marie
    Lacouture, Mario E.
    Holland, Eric C.
    Lassman, Andrew B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Stereotactic injection of DTI-015 into recurrent malignant gliomas: Phase I/II trial
    Hassenbusch, SJ
    Nardone, EM
    Levin, VA
    Leeds, N
    Pietronigro, D
    NEOPLASIA, 2003, 5 (01): : 9 - 16
  • [33] A phase I trial of intratumoral (IT) administration of reovirus in patients with histologically confirmed recurrent malignant gliomas (MG)
    Forsyth, P. A.
    Roldan, G.
    George, D.
    Wallace, C.
    Morris, D. G.
    Cairncross, G.
    Matthews, M. Vallee
    Markert, J.
    Gillespie, Y.
    Coffey, M.
    Thompson, B.
    Hamilton, M.
    NEURO-ONCOLOGY, 2006, 8 (04) : 442 - 442
  • [34] Phase I trial of vandetanib and oral etoposide (VP-16) for recurrent malignant gliomas (MG).
    Brickhouse, A.
    Vredenburgh, J. J.
    Gururangan, S.
    Reardon, D. A.
    Desjardins, A.
    Peters, K.
    Herndon, J. E.
    Norfleet, J.
    Marcello, J.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas
    Wagner, S. A.
    Desjardins, A.
    Reardon, D. A.
    Marcello, J.
    Herndon, J. E., II
    Quinn, J. A.
    Rich, J. N.
    Sathornsumetee, S.
    Friedman, H. S.
    Vredenburgh, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
    Reardon, DA
    Quinn, JA
    Vredenburgh, J
    Rich, JN
    Gururangan, S
    Badruddoja, M
    Herndon, JE
    Dowell, JM
    Friedman, AH
    Friedman, HS
    CANCER, 2005, 103 (02) : 329 - 338
  • [37] Phase I study of karenitecin in the treatment of recurrent malignant gliomas (MG)
    Lesser, GJ
    Grossman, SA
    Carson, K
    Phupanich, S
    Batchelor, T
    Peereboom, D
    Nabors, LB
    Supko, J
    Hausheer, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 120S - 120S
  • [38] Recurrent malignant gliomas: Comparison of different phase II studies
    Soffietti, R
    Ruda, R
    Bradac, GB
    Vasario, E
    Schiffer, D
    NEUROLOGY, 1996, 46 (02) : 66004 - 66004
  • [39] A phase II trial of poly-ICLC in the management of recurrent or progressive pediatric low grade gliomas
    Hartman, Lisa R.
    Durden, Donald L.
    CANCER RESEARCH, 2012, 72
  • [40] Phase II trial of imatinib mesylate (GLEEVEC) and hydroxyurea for adults with recurrent/progressive meningioma
    Goli, Krishna
    Bota, Daniela
    Desjardins, Annick
    Rich, Jeremy
    Vredenburgh, James
    Quinn, Jennifer
    Sathornsumetee, Sith
    Salvado, August
    Friedman, Henry
    Reardon, David
    NEURO-ONCOLOGY, 2007, 9 (04) : 519 - 519
12345